Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physical activity, low-calorie diet, and aspirin effects on inflammation and HPA axis activity in women with abdominal obesity and metabolic syndrome
2007-002600-18Phase 4Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Jun 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of aspirin in cardiometabolic risk (CMR) and Abdominal adiposity (ABCD) (2 arms), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Primary endpoint: effect on inflammation and HPA axis activity. Started Jun 2007; status: completed.
02
Drugs
aspirin
03
Conditions
cardiometabolic risk (CMR)Abdominal adiposity (ABCD)
Beyond the preview
Go deeper on 2007-002600-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002600-18.